Yeah, whilst @bridog 's points are sensible, the company gave...

Yeah, whilst @bridog 's points are sensible, the company gave the distinct impression we would be aware of data by now. Personally I am sick to death of bio-techs talking up time lines and results. Investing without irrational exuberance is hard enough, without companies talking things up.

I have full confidence in MSB eventually getting partnerships and results, but I think SI has learnt he needs to pipe down a bit so we will have to wait. His comments about continued high mortality in cohorts during the ARDS trials were not helpful. I suspect we will get full ARdS data with a confirmation of Novartis' continued partnership in one announcement.